Rockwell Medical (RMTI) Capital Expenditures (2010 - 2026)

Rockwell Medical (RMTI) has reported Capital Expenditures for 17 consecutive years, with $617000.0 the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Capital Expenditures rose 276.22% year-over-year to $617000.0; the trailing twelve-month figure through Jun 2026 stood at $1.4 million (up 66.91% YoY), and the FY2025 full-year result was $542000.0, down 46.39% from the prior year.
• Capital Expenditures climbed to $617000.0 in Q2 2026 per RMTI's latest filing, from $425000.0 in the prior quarter.
• Across five years, Capital Expenditures topped out at $617000.0 in Q2 2026 and bottomed at -$80000.0 in Q3 2022.
• Historically, Capital Expenditures has averaged $175555.6 across 5 years, with a median of $142000.0 in 2023.
• The sharpest annual moves came in 2022 and 2024: Capital Expenditures tumbled 162.99% in 2022, then jumped 1093.75% in 2024.
• Over 5 years, Capital Expenditures stood at $281000.0 in 2022, then tumbled by 84.7% to $43000.0 in 2023, then surged by 818.6% to $395000.0 in 2024, then sank by 78.23% to $86000.0 in 2025, then jumped by 617.44% to $617000.0 in 2026.
• According to Business Quant data, Capital Expenditures over the past three periods registered $617000.0, $425000.0, and $86000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.